Bayer's Monsanto has sued Pfizer, BioNTech and Moderna for allegedly misusing its messenger RNA technology in COVID vaccines.
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
The Manila Times on MSN
Bayer sues COVID vaccine makers over mRNA technology
Bayer's Monsanto sued COVID-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court on Tuesday for ...
The study’s authors include scientists from Colorado State University, the CSU Veterinary Diagnostic Laboratories and the ...
CoV-2 variants now spread less efficiently in animals, lowering concerns that animal reservoirs could generate new variants ...
Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most ...
Dr Melanie Ivarsson will on Monday be named chief executive of the Health Data Research Service (HDRS), which will give ...
Acuitas Therapeutics shelled out an undisclosed sum to acquire a majority stake in Montreal-based and privately held RNA Technologies & Therapeutics in a move to scale the latter’s operations around ...
According to Bayer, vaccine manufacturers including Pfizer, BioNTech, and Moderna copied technology pioneered by Monsanto in ...
USU chemists’ CRISPR discovery could lead to single diagnostic test for viruses like COVID, flu, RSV
Researchers at Utah State University revealed new details about CRISPR immune system defenses, such as Cas12a3 systems, that ...
AZoLifeSciences on MSN
Synthetic RNA platform converts viral replication into detectable cellular signals
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
Hong Kong investors can now trade in their first mRNA concept stock, following the strong trading debut for Suzhou Ribo Life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback